Immunovant, Inc.
IMVT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in Immunovant, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −14 vs. Q1 2022
- Shares held
- 40.1M
- +744.9K (+1.9%) vs. Q1 2022
- Total value
- $156.5M
- −$61.2M (−28.1%) vs. Q1 2022
- New holders
- 12
- 31 more added
- Sold out
- 26
- 31 more reduced
4 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 226 | $4.25B |
| Q1 2026 | 216 | $2.75B |
| Q4 2025 | 197 | $2.76B |
| Q3 2025 | 186 | $1.53B |
| Q2 2025 | 169 | $1.54B |
| Q1 2025 | 194 | $1.62B |
| Q4 2024 | 187 | $1.98B |
| Q3 2024 | 182 | $2.26B |
| Q2 2024 | 197 | $1.97B |
| Q1 2024 | 209 | $2.27B |
| Q4 2023 | 228 | $2.88B |
| Q3 2023 | 181 | $2.57B |
| Q2 2023 | 147 | $1.05B |
| Q1 2023 | 142 | $903.7M |
| Q4 2022 | 133 | $1.00B |
| Q3 2022 | 112 | $238.1M |
| Q2 2022 | 94 | $156.5M |
| Q1 2022 | 112 | $218.6M |
| Q4 2021 | 118 | $322.4M |
| Q3 2021 | 119 | $293.6M |
| Q2 2021 | 110 | $407.5M |
| Q1 2021 | 120 | $654.3M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −44,668−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −41,178−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −35,382−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −28,037−100.0% | Sold out |
| MetLife Investment Management | 0 | $0 | 0.00% | −25,184−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −23,655−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,250−100.0% | Sold out |
| Manufacturers Life Insurance Company, The | 0 | $0 | 0.00% | −20,276−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −19,854−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −18,700−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −14,616−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −14,300−100.0% | Sold out |
| Creative Financial Designs Inc | 0 | $0 | 0.00% | −13,965−100.0% | Sold out |
| Delphia (USA) Inc. | 0 | $0 | 0.00% | −13,713−100.0% | Sold out |
| Prospera Financial Services Inc | 0 | $0 | 0.00% | −9,135−100.0% | Sold out |
| Metropolitan Life Insurance Co | 0 | $0 | 0.00% | −2,758−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −2,402−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −1,400−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Heritage Wealth Management, LLC | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| IndexIQ Advisors LLC | – | – | – | – | Not filed |
| Parametric Portfolio Associates LLC | – | – | – | – | Not filed |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |